Preexposure Prophylaxis Implementation in a Reproductive Health Setting : Perspectives From Planned Parenthood Providers and Leaders
Integrating pregnancy and HIV prevention services would make reproductive health care settings an optimal venue for the promotion and delivery of preexposure prophylaxis (PrEP) to cisgender women. However, these settings have been slow to adopt PrEP. Planned parenthood clinicians and leaders possess critical insight that can help accelerate PrEP implementation in reproductive health care settings and elements of the Consolidated Framework for Implementation Research (i.e., relative priority of the intervention to staff, implementation climate, available resources to implement the intervention, and staff access to knowledge and information about the intervention) can shed light on elements of Planned Parenthood's inner setting that can facilitate PrEP implementation. In this study, individual 60-min interviews were conducted with clinical care team members (n = 10), leadership team members (n = 6), and center managers (n = 2) to explore their perspectives on PrEP implementation and associated training needs. Transcripts were transcribed verbatim and thematically analyzed. Despite having variable PrEP knowledge, participants (100% women, 61% non-Hispanic White) expressed positive attitudes toward implementing PrEP. Barriers and facilitators toward providing PrEP were reported at the structural, provider, and patient levels. Participants desired PrEP training that incorporated culturally competent patient-provider communication. Although participants identified ways that Planned Parenthood uniquely enabled PrEP implementation, barriers must be overcome to optimize promotion and delivery of PrEP to cisgender women.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Health promotion practice - 24(2023), 4 vom: 15. Juli, Seite 764-775 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wilbourn, Brittany [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-HIV Agents |
|---|
| Anmerkungen: |
Date Completed 07.07.2023 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/15248399221086616 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339438088 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339438088 | ||
| 003 | DE-627 | ||
| 005 | 20240312232931.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/15248399221086616 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM339438088 | ||
| 035 | |a (NLM)35414273 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wilbourn, Brittany |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Preexposure Prophylaxis Implementation in a Reproductive Health Setting |b Perspectives From Planned Parenthood Providers and Leaders |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.07.2023 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Integrating pregnancy and HIV prevention services would make reproductive health care settings an optimal venue for the promotion and delivery of preexposure prophylaxis (PrEP) to cisgender women. However, these settings have been slow to adopt PrEP. Planned parenthood clinicians and leaders possess critical insight that can help accelerate PrEP implementation in reproductive health care settings and elements of the Consolidated Framework for Implementation Research (i.e., relative priority of the intervention to staff, implementation climate, available resources to implement the intervention, and staff access to knowledge and information about the intervention) can shed light on elements of Planned Parenthood's inner setting that can facilitate PrEP implementation. In this study, individual 60-min interviews were conducted with clinical care team members (n = 10), leadership team members (n = 6), and center managers (n = 2) to explore their perspectives on PrEP implementation and associated training needs. Transcripts were transcribed verbatim and thematically analyzed. Despite having variable PrEP knowledge, participants (100% women, 61% non-Hispanic White) expressed positive attitudes toward implementing PrEP. Barriers and facilitators toward providing PrEP were reported at the structural, provider, and patient levels. Participants desired PrEP training that incorporated culturally competent patient-provider communication. Although participants identified ways that Planned Parenthood uniquely enabled PrEP implementation, barriers must be overcome to optimize promotion and delivery of PrEP to cisgender women | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a attitudes | |
| 650 | 4 | |a clinical services | |
| 650 | 4 | |a implementation | |
| 650 | 4 | |a knowledge | |
| 650 | 4 | |a preexposure prophylaxis | |
| 650 | 4 | |a women’s health | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 700 | 1 | |a Ogburn, Damon F |e verfasserin |4 aut | |
| 700 | 1 | |a Safon, Cara B |e verfasserin |4 aut | |
| 700 | 1 | |a Galvao, Rachel W |e verfasserin |4 aut | |
| 700 | 1 | |a Kershaw, Trace S |e verfasserin |4 aut | |
| 700 | 1 | |a Willie, Tiara C |e verfasserin |4 aut | |
| 700 | 1 | |a Taggart, Tamara |e verfasserin |4 aut | |
| 700 | 1 | |a Caldwell, Abigail |e verfasserin |4 aut | |
| 700 | 1 | |a Kaplan, Clair |e verfasserin |4 aut | |
| 700 | 1 | |a Phillips, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Calabrese, Sarah K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Health promotion practice |d 2003 |g 24(2023), 4 vom: 15. Juli, Seite 764-775 |w (DE-627)NLM143291424 |x 1524-8399 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:4 |g day:15 |g month:07 |g pages:764-775 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/15248399221086616 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 4 |b 15 |c 07 |h 764-775 | ||